Jiwa Bio-Pharm Holdings Limited has sold a majority stake to U-Home Group International Ltd.
U-Home Group International Litd. has acquired 72.19% of the issued share capital in Jiwa Bio-Pharm Holdings Limited, for a consideration of US$35.9 million.
The company trades in pharmaceutical and healthcare products, research and development of chemical and biological products, and investment and treasury functions.
U-Home Group International Ltd. is a company owned by Yuhua Enterprises Co Ltd.
Oaklins' team in Hong Kong acted as financial advisor to Jiwa Bio-Pharm Holdings Limited regarding this transaction.
Talk to the deal team
Related deals
sigo green GmbH has acquired the assets of sigo GmbH in the context of the insolvency in self-administration
sigo GmbH has sold its assets as part of a transferring reorganization to sigo green GmbH.
Learn moreDelaware Valley Floral Group has been acquired by Staple Street Capital
The owners of Delaware Valley Floral Group, Inc. (DVFG) have sold the company to Staple Street Capital.
Learn moreOTS has received valuation services
OTS Open Travel Services AG, a subsidiary of MTS Globe Group, is a leading hotel trading provider based in Glattbrugg, Switzerland. OTS acts as a B2B hotel trading intermediary paring travel sellers, such as travel agencies and tour operators with accommodation providers.
Learn more